Annual Accounts Receivable
$512.00 M
+$4.60 M+0.91%
31 December 2023
Summary:
West Pharmaceutical Services annual accounts receivable is currently $512.00 million, with the most recent change of +$4.60 million (+0.91%) on 31 December 2023. During the last 3 years, it has risen by +$126.70 million (+32.88%). WST annual accounts receivable is now at all-time high.WST Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Accounts Receivable
$524.30 M
+$44.90 M+9.37%
30 September 2024
Summary:
West Pharmaceutical Services quarterly accounts receivable is currently $524.30 million, with the most recent change of +$44.90 million (+9.37%) on 30 September 2024. Over the past year, it has increased by +$5.20 million (+1.00%). WST quarterly accounts receivable is now -1.89% below its all-time high of $534.40 million, reached on 30 June 2023.WST Quarterly Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
WST Accounts Receivable Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +0.9% | +1.0% |
| 3 y3 years | +32.9% | +10.1% |
| 5 y5 years | +77.7% | +65.9% |
WST Accounts Receivable High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +32.9% | -1.9% | +10.1% |
| 5 y | 5 years | at high | +77.7% | -1.9% | +65.9% |
| alltime | all time | at high | +853.5% | -1.9% | +876.4% |
West Pharmaceutical Services Accounts Receivable History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $524.30 M(+9.4%) |
| June 2024 | - | $479.40 M(-8.5%) |
| Mar 2024 | - | $524.00 M(+2.3%) |
| Dec 2023 | $512.00 M(+0.9%) | $512.00 M(-1.4%) |
| Sept 2023 | - | $519.10 M(-2.9%) |
| June 2023 | - | $534.40 M(+4.1%) |
| Mar 2023 | - | $513.40 M(+1.2%) |
| Dec 2022 | $507.40 M(+3.8%) | $507.40 M(+4.6%) |
| Sept 2022 | - | $485.30 M(-8.2%) |
| June 2022 | - | $528.40 M(+6.0%) |
| Mar 2022 | - | $498.70 M(+2.0%) |
| Dec 2021 | $489.00 M(+26.9%) | $489.00 M(+2.6%) |
| Sept 2021 | - | $476.40 M(-0.9%) |
| June 2021 | - | $480.50 M(+3.2%) |
| Mar 2021 | - | $465.70 M(+20.9%) |
| Dec 2020 | $385.30 M(+20.7%) | $385.30 M(+3.3%) |
| Sept 2020 | - | $373.00 M(+9.5%) |
| June 2020 | - | $340.60 M(+2.3%) |
| Mar 2020 | - | $333.00 M(+4.3%) |
| Dec 2019 | $319.30 M(+10.8%) | $319.30 M(+1.0%) |
| Sept 2019 | - | $316.10 M(-4.4%) |
| June 2019 | - | $330.80 M(+4.0%) |
| Mar 2019 | - | $318.20 M(+10.4%) |
| Dec 2018 | $288.20 M(+13.8%) | $288.20 M(-4.9%) |
| Sept 2018 | - | $302.90 M(+2.1%) |
| June 2018 | - | $296.70 M(+2.2%) |
| Mar 2018 | - | $290.40 M(+14.7%) |
| Dec 2017 | $253.20 M(+26.3%) | $253.20 M(+0.6%) |
| Sept 2017 | - | $251.80 M(+3.9%) |
| June 2017 | - | $242.40 M(+7.8%) |
| Mar 2017 | - | $224.80 M(+12.1%) |
| Dec 2016 | $200.50 M(+10.5%) | $200.50 M(-4.3%) |
| Sept 2016 | - | $209.50 M(-4.3%) |
| June 2016 | - | $219.00 M(+4.5%) |
| Mar 2016 | - | $209.60 M(+15.5%) |
| Dec 2015 | $181.40 M(+1.3%) | $181.40 M(-6.8%) |
| Sept 2015 | - | $194.60 M(-2.1%) |
| June 2015 | - | $198.80 M(+4.9%) |
| Mar 2015 | - | $189.50 M(+5.9%) |
| Dec 2014 | $179.00 M(-3.6%) | $179.00 M(-8.6%) |
| Sept 2014 | - | $195.90 M(-6.5%) |
| June 2014 | - | $209.60 M(+0.4%) |
| Mar 2014 | - | $208.70 M(+12.4%) |
| Dec 2013 | $185.70 M(+6.1%) | $185.70 M(-6.3%) |
| Sept 2013 | - | $198.20 M(+1.5%) |
| June 2013 | - | $195.30 M(+3.3%) |
| Mar 2013 | - | $189.00 M(+8.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2012 | $175.00 M(+18.9%) | $175.00 M(-4.3%) |
| Sept 2012 | - | $182.90 M(-1.1%) |
| June 2012 | - | $185.00 M(+5.1%) |
| Mar 2012 | - | $176.00 M(+19.6%) |
| Dec 2011 | $147.20 M(+16.5%) | $147.20 M(-3.9%) |
| Sept 2011 | - | $153.10 M(-7.6%) |
| June 2011 | - | $165.70 M(+2.8%) |
| Mar 2011 | - | $161.20 M(+27.5%) |
| Dec 2010 | $126.40 M(-8.9%) | $126.40 M(-11.5%) |
| Sept 2010 | - | $142.80 M(-2.0%) |
| June 2010 | - | $145.70 M(-0.6%) |
| Mar 2010 | - | $146.60 M(+5.7%) |
| Dec 2009 | $138.70 M(+7.9%) | $138.70 M(-2.7%) |
| Sept 2009 | - | $142.50 M(-0.6%) |
| June 2009 | - | $143.40 M(+4.5%) |
| Mar 2009 | - | $137.20 M(+6.7%) |
| Dec 2008 | $128.60 M(-5.5%) | $128.60 M(-8.5%) |
| Sept 2008 | - | $140.60 M(-11.7%) |
| June 2008 | - | $159.20 M(+4.8%) |
| Mar 2008 | - | $151.90 M(+11.6%) |
| Dec 2007 | $136.10 M(+24.3%) | $136.10 M(-0.5%) |
| Sept 2007 | - | $136.80 M(+0.1%) |
| June 2007 | - | $136.70 M(-4.6%) |
| Mar 2007 | - | $143.30 M(+30.9%) |
| Dec 2006 | $109.50 M(+2.0%) | $109.50 M(-8.9%) |
| Sept 2006 | - | $120.20 M(-3.3%) |
| June 2006 | - | $124.30 M(+0.1%) |
| Mar 2006 | - | $124.20 M(+15.6%) |
| Dec 2005 | $107.40 M(+47.3%) | $107.40 M(+2.5%) |
| Sept 2005 | - | $104.80 M(+1.5%) |
| June 2005 | - | $103.30 M(+22.5%) |
| Mar 2005 | - | $84.30 M(+15.6%) |
| Dec 2004 | $72.90 M(+0.8%) | $72.90 M(-7.5%) |
| Sept 2004 | - | $78.80 M(-2.7%) |
| June 2004 | - | $81.00 M(+12.0%) |
| Dec 2003 | $72.30 M(+8.6%) | $72.30 M(-5.2%) |
| Sept 2003 | - | $76.30 M(-5.7%) |
| June 2003 | - | $80.90 M(+11.4%) |
| Mar 2003 | - | $72.60 M(+9.0%) |
| Dec 2002 | $66.60 M(+7.8%) | $66.60 M(+5.4%) |
| Sept 2002 | - | $63.20 M(-10.6%) |
| June 2002 | - | $70.70 M(-0.3%) |
| Mar 2002 | - | $70.90 M(+14.7%) |
| Dec 2001 | $61.80 M(+15.1%) | $61.80 M(-17.6%) |
| Sept 2001 | - | $75.00 M(+7.6%) |
| June 2001 | - | $69.70 M(+29.8%) |
| Dec 2000 | $53.70 M | $53.70 M |
FAQ
- What is West Pharmaceutical Services annual accounts receivable?
- What is the all time high annual accounts receivable for West Pharmaceutical Services?
- What is West Pharmaceutical Services annual accounts receivable year-on-year change?
- What is West Pharmaceutical Services quarterly accounts receivable?
- What is the all time high quarterly accounts receivable for West Pharmaceutical Services?
- What is West Pharmaceutical Services quarterly accounts receivable year-on-year change?
What is West Pharmaceutical Services annual accounts receivable?
The current annual accounts receivable of WST is $512.00 M
What is the all time high annual accounts receivable for West Pharmaceutical Services?
West Pharmaceutical Services all-time high annual accounts receivable is $512.00 M
What is West Pharmaceutical Services annual accounts receivable year-on-year change?
Over the past year, WST annual accounts receivable has changed by +$4.60 M (+0.91%)
What is West Pharmaceutical Services quarterly accounts receivable?
The current quarterly accounts receivable of WST is $524.30 M
What is the all time high quarterly accounts receivable for West Pharmaceutical Services?
West Pharmaceutical Services all-time high quarterly accounts receivable is $534.40 M
What is West Pharmaceutical Services quarterly accounts receivable year-on-year change?
Over the past year, WST quarterly accounts receivable has changed by +$5.20 M (+1.00%)